[Federal Register Volume 61, Number 52 (Friday, March 15, 1996)]
[Notices]
[Page 10789]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-6224]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 19, 1995, and published in the Federal 
Register on October 25, 1995 (60 FR 54708), Nycomed, Inc., 33 Riverside 
Avenue, Rensselaer, New York 12144, made application to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of meperidine (9230), a basic class of controlled 
substance listed in Schedule II.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Nycomed, Inc. to manufacture the 
listed controlled substance is consistent with the public interest at 
this time. Therefore, pursuant to Section 303 of the Comprehensive Drug 
Abuse Prevention and Control Act of 1970 and Title 21, Code of Federal 
Regulations, Sec. 1301.54(e), the Deputy Assistant Administrator, 
Office of Diversion Control, hereby orders that the application 
submitted by the above firm for registration as a bulk manufacturer of 
the basic class of controlled substance listed above is granted.

    Dated: March 5, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-6224 Filed 3-14-96; 8:45 am]
BILLING CODE 4410-09-M